News Esketamine: NICE’s appraisal was unfair, appeal panel rules BMJ 2022; 378 doi: https://doi.org/10.1136/bmj.o2192 (Published 08 September 2022) Cite this as: BMJ 2022;378:o2192 Article Related content Metrics Responses Peer review Related articles News NICE reconsiders esketamine for depression Published: 04 September 2020; BMJ 370 doi:10.1136/bmj.m3479 News Esketamine for treatment resistant depression is not recommended by NICE Published: 28 January 2020; BMJ 368 doi:10.1136/bmj.m329 See more When I use a word . . . . The Lelamour Herbal BMJ January 27, 2023, 380 p225; DOI: https://doi.org/10.1136/bmj.p225 A bill before parliament for the right to breath clean air BMJ January 27, 2023, 380 p224; DOI: https://doi.org/10.1136/bmj.p224 “Functional disorders”: one of medicine’s biggest failures BMJ January 27, 2023, 380 p221; DOI: https://doi.org/10.1136/bmj.p221 Medical academic workforce is under threat without urgent action on pay and pensions, say peers BMJ January 27, 2023, 380 p220; DOI: https://doi.org/10.1136/bmj.p220 Maternity care: Entonox is withdrawn from some hospitals because of risk to staff from high exposure BMJ January 27, 2023, 380 p212; DOI: https://doi.org/10.1136/bmj.p212
